Global IDH1 Antibody Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global IDH1 Antibody market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global IDH1 Antibody market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global IDH1 Antibody market size and forecasts, in consumption value ($ Million), sales quantity (ml), and average selling prices (US$/ml), 2018-2029
Global IDH1 Antibody market size and forecasts by region and country, in consumption value ($ Million), sales quantity (ml), and average selling prices (US$/ml), 2018-2029
Global IDH1 Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (ml), and average selling prices (US$/ml), 2018-2029
Global IDH1 Antibody market shares of main players, shipments in revenue ($ Million), sales quantity (ml), and ASP (US$/ml), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for IDH1 Antibody
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global IDH1 Antibody market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, GeneTex, Abcam, BosterBio and Proteintech Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
IDH1 Antibody market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe IDH1 Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of IDH1 Antibody, with price, sales, revenue and global market share of IDH1 Antibody from 2018 to 2023.
Chapter 3, the IDH1 Antibody competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the IDH1 Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and IDH1 Antibody market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of IDH1 Antibody.
Chapter 14 and 15, to describe IDH1 Antibody sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global IDH1 Antibody market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global IDH1 Antibody market size and forecasts, in consumption value ($ Million), sales quantity (ml), and average selling prices (US$/ml), 2018-2029
Global IDH1 Antibody market size and forecasts by region and country, in consumption value ($ Million), sales quantity (ml), and average selling prices (US$/ml), 2018-2029
Global IDH1 Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (ml), and average selling prices (US$/ml), 2018-2029
Global IDH1 Antibody market shares of main players, shipments in revenue ($ Million), sales quantity (ml), and ASP (US$/ml), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for IDH1 Antibody
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global IDH1 Antibody market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, GeneTex, Abcam, BosterBio and Proteintech Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
IDH1 Antibody market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Monoclonal
- Polyclonal
- Immunochemistry (IHC)
- Immunofluorescence (IF)
- Immunoprecipitation (IP)
- Western Blot (WB)
- ELISA
- Others
- Merck
- GeneTex
- Abcam
- BosterBio
- Proteintech Group
- Abnova Corporation
- Novus Biologicals
- NSJ Bioreagents
- LifeSpan BioSciences
- Abeomics
- ProSci
- QED Bioscience
- Cell Signaling Technology
- RayBiotech
- EpiGentek
- Enzo Life Sciences
- OriGene Technologies
- Jingjie PTM BioLab
- Beijing Solarbio
- Biobyt
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe IDH1 Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of IDH1 Antibody, with price, sales, revenue and global market share of IDH1 Antibody from 2018 to 2023.
Chapter 3, the IDH1 Antibody competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the IDH1 Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and IDH1 Antibody market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of IDH1 Antibody.
Chapter 14 and 15, to describe IDH1 Antibody sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of IDH1 Antibody
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global IDH1 Antibody Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Monoclonal
1.3.3 Polyclonal
1.4 Market Analysis by Application
1.4.1 Overview: Global IDH1 Antibody Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Immunochemistry (IHC)
1.4.3 Immunofluorescence (IF)
1.4.4 Immunoprecipitation (IP)
1.4.5 Western Blot (WB)
1.4.6 ELISA
1.4.7 Others
1.5 Global IDH1 Antibody Market Size & Forecast
1.5.1 Global IDH1 Antibody Consumption Value (2018 & 2022 & 2029)
1.5.2 Global IDH1 Antibody Sales Quantity (2018-2029)
1.5.3 Global IDH1 Antibody Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck IDH1 Antibody Product and Services
2.1.4 Merck IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 GeneTex
2.2.1 GeneTex Details
2.2.2 GeneTex Major Business
2.2.3 GeneTex IDH1 Antibody Product and Services
2.2.4 GeneTex IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GeneTex Recent Developments/Updates
2.3 Abcam
2.3.1 Abcam Details
2.3.2 Abcam Major Business
2.3.3 Abcam IDH1 Antibody Product and Services
2.3.4 Abcam IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Abcam Recent Developments/Updates
2.4 BosterBio
2.4.1 BosterBio Details
2.4.2 BosterBio Major Business
2.4.3 BosterBio IDH1 Antibody Product and Services
2.4.4 BosterBio IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BosterBio Recent Developments/Updates
2.5 Proteintech Group
2.5.1 Proteintech Group Details
2.5.2 Proteintech Group Major Business
2.5.3 Proteintech Group IDH1 Antibody Product and Services
2.5.4 Proteintech Group IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Proteintech Group Recent Developments/Updates
2.6 Abnova Corporation
2.6.1 Abnova Corporation Details
2.6.2 Abnova Corporation Major Business
2.6.3 Abnova Corporation IDH1 Antibody Product and Services
2.6.4 Abnova Corporation IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Abnova Corporation Recent Developments/Updates
2.7 Novus Biologicals
2.7.1 Novus Biologicals Details
2.7.2 Novus Biologicals Major Business
2.7.3 Novus Biologicals IDH1 Antibody Product and Services
2.7.4 Novus Biologicals IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novus Biologicals Recent Developments/Updates
2.8 NSJ Bioreagents
2.8.1 NSJ Bioreagents Details
2.8.2 NSJ Bioreagents Major Business
2.8.3 NSJ Bioreagents IDH1 Antibody Product and Services
2.8.4 NSJ Bioreagents IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 NSJ Bioreagents Recent Developments/Updates
2.9 LifeSpan BioSciences
2.9.1 LifeSpan BioSciences Details
2.9.2 LifeSpan BioSciences Major Business
2.9.3 LifeSpan BioSciences IDH1 Antibody Product and Services
2.9.4 LifeSpan BioSciences IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 LifeSpan BioSciences Recent Developments/Updates
2.10 Abeomics
2.10.1 Abeomics Details
2.10.2 Abeomics Major Business
2.10.3 Abeomics IDH1 Antibody Product and Services
2.10.4 Abeomics IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Abeomics Recent Developments/Updates
2.11 ProSci
2.11.1 ProSci Details
2.11.2 ProSci Major Business
2.11.3 ProSci IDH1 Antibody Product and Services
2.11.4 ProSci IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 ProSci Recent Developments/Updates
2.12 QED Bioscience
2.12.1 QED Bioscience Details
2.12.2 QED Bioscience Major Business
2.12.3 QED Bioscience IDH1 Antibody Product and Services
2.12.4 QED Bioscience IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 QED Bioscience Recent Developments/Updates
2.13 Cell Signaling Technology
2.13.1 Cell Signaling Technology Details
2.13.2 Cell Signaling Technology Major Business
2.13.3 Cell Signaling Technology IDH1 Antibody Product and Services
2.13.4 Cell Signaling Technology IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Cell Signaling Technology Recent Developments/Updates
2.14 RayBiotech
2.14.1 RayBiotech Details
2.14.2 RayBiotech Major Business
2.14.3 RayBiotech IDH1 Antibody Product and Services
2.14.4 RayBiotech IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 RayBiotech Recent Developments/Updates
2.15 EpiGentek
2.15.1 EpiGentek Details
2.15.2 EpiGentek Major Business
2.15.3 EpiGentek IDH1 Antibody Product and Services
2.15.4 EpiGentek IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 EpiGentek Recent Developments/Updates
2.16 Enzo Life Sciences
2.16.1 Enzo Life Sciences Details
2.16.2 Enzo Life Sciences Major Business
2.16.3 Enzo Life Sciences IDH1 Antibody Product and Services
2.16.4 Enzo Life Sciences IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Enzo Life Sciences Recent Developments/Updates
2.17 OriGene Technologies
2.17.1 OriGene Technologies Details
2.17.2 OriGene Technologies Major Business
2.17.3 OriGene Technologies IDH1 Antibody Product and Services
2.17.4 OriGene Technologies IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 OriGene Technologies Recent Developments/Updates
2.18 Jingjie PTM BioLab
2.18.1 Jingjie PTM BioLab Details
2.18.2 Jingjie PTM BioLab Major Business
2.18.3 Jingjie PTM BioLab IDH1 Antibody Product and Services
2.18.4 Jingjie PTM BioLab IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Jingjie PTM BioLab Recent Developments/Updates
2.19 Beijing Solarbio
2.19.1 Beijing Solarbio Details
2.19.2 Beijing Solarbio Major Business
2.19.3 Beijing Solarbio IDH1 Antibody Product and Services
2.19.4 Beijing Solarbio IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Beijing Solarbio Recent Developments/Updates
2.20 Biobyt
2.20.1 Biobyt Details
2.20.2 Biobyt Major Business
2.20.3 Biobyt IDH1 Antibody Product and Services
2.20.4 Biobyt IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Biobyt Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IDH1 ANTIBODY BY MANUFACTURER
3.1 Global IDH1 Antibody Sales Quantity by Manufacturer (2018-2023)
3.2 Global IDH1 Antibody Revenue by Manufacturer (2018-2023)
3.3 Global IDH1 Antibody Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of IDH1 Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 IDH1 Antibody Manufacturer Market Share in 2022
3.4.2 Top 6 IDH1 Antibody Manufacturer Market Share in 2022
3.5 IDH1 Antibody Market: Overall Company Footprint Analysis
3.5.1 IDH1 Antibody Market: Region Footprint
3.5.2 IDH1 Antibody Market: Company Product Type Footprint
3.5.3 IDH1 Antibody Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global IDH1 Antibody Market Size by Region
4.1.1 Global IDH1 Antibody Sales Quantity by Region (2018-2029)
4.1.2 Global IDH1 Antibody Consumption Value by Region (2018-2029)
4.1.3 Global IDH1 Antibody Average Price by Region (2018-2029)
4.2 North America IDH1 Antibody Consumption Value (2018-2029)
4.3 Europe IDH1 Antibody Consumption Value (2018-2029)
4.4 Asia-Pacific IDH1 Antibody Consumption Value (2018-2029)
4.5 South America IDH1 Antibody Consumption Value (2018-2029)
4.6 Middle East and Africa IDH1 Antibody Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global IDH1 Antibody Sales Quantity by Type (2018-2029)
5.2 Global IDH1 Antibody Consumption Value by Type (2018-2029)
5.3 Global IDH1 Antibody Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global IDH1 Antibody Sales Quantity by Application (2018-2029)
6.2 Global IDH1 Antibody Consumption Value by Application (2018-2029)
6.3 Global IDH1 Antibody Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America IDH1 Antibody Sales Quantity by Type (2018-2029)
7.2 North America IDH1 Antibody Sales Quantity by Application (2018-2029)
7.3 North America IDH1 Antibody Market Size by Country
7.3.1 North America IDH1 Antibody Sales Quantity by Country (2018-2029)
7.3.2 North America IDH1 Antibody Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe IDH1 Antibody Sales Quantity by Type (2018-2029)
8.2 Europe IDH1 Antibody Sales Quantity by Application (2018-2029)
8.3 Europe IDH1 Antibody Market Size by Country
8.3.1 Europe IDH1 Antibody Sales Quantity by Country (2018-2029)
8.3.2 Europe IDH1 Antibody Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific IDH1 Antibody Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific IDH1 Antibody Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific IDH1 Antibody Market Size by Region
9.3.1 Asia-Pacific IDH1 Antibody Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific IDH1 Antibody Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America IDH1 Antibody Sales Quantity by Type (2018-2029)
10.2 South America IDH1 Antibody Sales Quantity by Application (2018-2029)
10.3 South America IDH1 Antibody Market Size by Country
10.3.1 South America IDH1 Antibody Sales Quantity by Country (2018-2029)
10.3.2 South America IDH1 Antibody Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa IDH1 Antibody Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa IDH1 Antibody Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa IDH1 Antibody Market Size by Country
11.3.1 Middle East & Africa IDH1 Antibody Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa IDH1 Antibody Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 IDH1 Antibody Market Drivers
12.2 IDH1 Antibody Market Restraints
12.3 IDH1 Antibody Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of IDH1 Antibody and Key Manufacturers
13.2 Manufacturing Costs Percentage of IDH1 Antibody
13.3 IDH1 Antibody Production Process
13.4 IDH1 Antibody Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 IDH1 Antibody Typical Distributors
14.3 IDH1 Antibody Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of IDH1 Antibody
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global IDH1 Antibody Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Monoclonal
1.3.3 Polyclonal
1.4 Market Analysis by Application
1.4.1 Overview: Global IDH1 Antibody Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Immunochemistry (IHC)
1.4.3 Immunofluorescence (IF)
1.4.4 Immunoprecipitation (IP)
1.4.5 Western Blot (WB)
1.4.6 ELISA
1.4.7 Others
1.5 Global IDH1 Antibody Market Size & Forecast
1.5.1 Global IDH1 Antibody Consumption Value (2018 & 2022 & 2029)
1.5.2 Global IDH1 Antibody Sales Quantity (2018-2029)
1.5.3 Global IDH1 Antibody Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck IDH1 Antibody Product and Services
2.1.4 Merck IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 GeneTex
2.2.1 GeneTex Details
2.2.2 GeneTex Major Business
2.2.3 GeneTex IDH1 Antibody Product and Services
2.2.4 GeneTex IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GeneTex Recent Developments/Updates
2.3 Abcam
2.3.1 Abcam Details
2.3.2 Abcam Major Business
2.3.3 Abcam IDH1 Antibody Product and Services
2.3.4 Abcam IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Abcam Recent Developments/Updates
2.4 BosterBio
2.4.1 BosterBio Details
2.4.2 BosterBio Major Business
2.4.3 BosterBio IDH1 Antibody Product and Services
2.4.4 BosterBio IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BosterBio Recent Developments/Updates
2.5 Proteintech Group
2.5.1 Proteintech Group Details
2.5.2 Proteintech Group Major Business
2.5.3 Proteintech Group IDH1 Antibody Product and Services
2.5.4 Proteintech Group IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Proteintech Group Recent Developments/Updates
2.6 Abnova Corporation
2.6.1 Abnova Corporation Details
2.6.2 Abnova Corporation Major Business
2.6.3 Abnova Corporation IDH1 Antibody Product and Services
2.6.4 Abnova Corporation IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Abnova Corporation Recent Developments/Updates
2.7 Novus Biologicals
2.7.1 Novus Biologicals Details
2.7.2 Novus Biologicals Major Business
2.7.3 Novus Biologicals IDH1 Antibody Product and Services
2.7.4 Novus Biologicals IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novus Biologicals Recent Developments/Updates
2.8 NSJ Bioreagents
2.8.1 NSJ Bioreagents Details
2.8.2 NSJ Bioreagents Major Business
2.8.3 NSJ Bioreagents IDH1 Antibody Product and Services
2.8.4 NSJ Bioreagents IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 NSJ Bioreagents Recent Developments/Updates
2.9 LifeSpan BioSciences
2.9.1 LifeSpan BioSciences Details
2.9.2 LifeSpan BioSciences Major Business
2.9.3 LifeSpan BioSciences IDH1 Antibody Product and Services
2.9.4 LifeSpan BioSciences IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 LifeSpan BioSciences Recent Developments/Updates
2.10 Abeomics
2.10.1 Abeomics Details
2.10.2 Abeomics Major Business
2.10.3 Abeomics IDH1 Antibody Product and Services
2.10.4 Abeomics IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Abeomics Recent Developments/Updates
2.11 ProSci
2.11.1 ProSci Details
2.11.2 ProSci Major Business
2.11.3 ProSci IDH1 Antibody Product and Services
2.11.4 ProSci IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 ProSci Recent Developments/Updates
2.12 QED Bioscience
2.12.1 QED Bioscience Details
2.12.2 QED Bioscience Major Business
2.12.3 QED Bioscience IDH1 Antibody Product and Services
2.12.4 QED Bioscience IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 QED Bioscience Recent Developments/Updates
2.13 Cell Signaling Technology
2.13.1 Cell Signaling Technology Details
2.13.2 Cell Signaling Technology Major Business
2.13.3 Cell Signaling Technology IDH1 Antibody Product and Services
2.13.4 Cell Signaling Technology IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Cell Signaling Technology Recent Developments/Updates
2.14 RayBiotech
2.14.1 RayBiotech Details
2.14.2 RayBiotech Major Business
2.14.3 RayBiotech IDH1 Antibody Product and Services
2.14.4 RayBiotech IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 RayBiotech Recent Developments/Updates
2.15 EpiGentek
2.15.1 EpiGentek Details
2.15.2 EpiGentek Major Business
2.15.3 EpiGentek IDH1 Antibody Product and Services
2.15.4 EpiGentek IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 EpiGentek Recent Developments/Updates
2.16 Enzo Life Sciences
2.16.1 Enzo Life Sciences Details
2.16.2 Enzo Life Sciences Major Business
2.16.3 Enzo Life Sciences IDH1 Antibody Product and Services
2.16.4 Enzo Life Sciences IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Enzo Life Sciences Recent Developments/Updates
2.17 OriGene Technologies
2.17.1 OriGene Technologies Details
2.17.2 OriGene Technologies Major Business
2.17.3 OriGene Technologies IDH1 Antibody Product and Services
2.17.4 OriGene Technologies IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 OriGene Technologies Recent Developments/Updates
2.18 Jingjie PTM BioLab
2.18.1 Jingjie PTM BioLab Details
2.18.2 Jingjie PTM BioLab Major Business
2.18.3 Jingjie PTM BioLab IDH1 Antibody Product and Services
2.18.4 Jingjie PTM BioLab IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Jingjie PTM BioLab Recent Developments/Updates
2.19 Beijing Solarbio
2.19.1 Beijing Solarbio Details
2.19.2 Beijing Solarbio Major Business
2.19.3 Beijing Solarbio IDH1 Antibody Product and Services
2.19.4 Beijing Solarbio IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Beijing Solarbio Recent Developments/Updates
2.20 Biobyt
2.20.1 Biobyt Details
2.20.2 Biobyt Major Business
2.20.3 Biobyt IDH1 Antibody Product and Services
2.20.4 Biobyt IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Biobyt Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IDH1 ANTIBODY BY MANUFACTURER
3.1 Global IDH1 Antibody Sales Quantity by Manufacturer (2018-2023)
3.2 Global IDH1 Antibody Revenue by Manufacturer (2018-2023)
3.3 Global IDH1 Antibody Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of IDH1 Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 IDH1 Antibody Manufacturer Market Share in 2022
3.4.2 Top 6 IDH1 Antibody Manufacturer Market Share in 2022
3.5 IDH1 Antibody Market: Overall Company Footprint Analysis
3.5.1 IDH1 Antibody Market: Region Footprint
3.5.2 IDH1 Antibody Market: Company Product Type Footprint
3.5.3 IDH1 Antibody Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global IDH1 Antibody Market Size by Region
4.1.1 Global IDH1 Antibody Sales Quantity by Region (2018-2029)
4.1.2 Global IDH1 Antibody Consumption Value by Region (2018-2029)
4.1.3 Global IDH1 Antibody Average Price by Region (2018-2029)
4.2 North America IDH1 Antibody Consumption Value (2018-2029)
4.3 Europe IDH1 Antibody Consumption Value (2018-2029)
4.4 Asia-Pacific IDH1 Antibody Consumption Value (2018-2029)
4.5 South America IDH1 Antibody Consumption Value (2018-2029)
4.6 Middle East and Africa IDH1 Antibody Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global IDH1 Antibody Sales Quantity by Type (2018-2029)
5.2 Global IDH1 Antibody Consumption Value by Type (2018-2029)
5.3 Global IDH1 Antibody Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global IDH1 Antibody Sales Quantity by Application (2018-2029)
6.2 Global IDH1 Antibody Consumption Value by Application (2018-2029)
6.3 Global IDH1 Antibody Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America IDH1 Antibody Sales Quantity by Type (2018-2029)
7.2 North America IDH1 Antibody Sales Quantity by Application (2018-2029)
7.3 North America IDH1 Antibody Market Size by Country
7.3.1 North America IDH1 Antibody Sales Quantity by Country (2018-2029)
7.3.2 North America IDH1 Antibody Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe IDH1 Antibody Sales Quantity by Type (2018-2029)
8.2 Europe IDH1 Antibody Sales Quantity by Application (2018-2029)
8.3 Europe IDH1 Antibody Market Size by Country
8.3.1 Europe IDH1 Antibody Sales Quantity by Country (2018-2029)
8.3.2 Europe IDH1 Antibody Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific IDH1 Antibody Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific IDH1 Antibody Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific IDH1 Antibody Market Size by Region
9.3.1 Asia-Pacific IDH1 Antibody Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific IDH1 Antibody Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America IDH1 Antibody Sales Quantity by Type (2018-2029)
10.2 South America IDH1 Antibody Sales Quantity by Application (2018-2029)
10.3 South America IDH1 Antibody Market Size by Country
10.3.1 South America IDH1 Antibody Sales Quantity by Country (2018-2029)
10.3.2 South America IDH1 Antibody Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa IDH1 Antibody Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa IDH1 Antibody Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa IDH1 Antibody Market Size by Country
11.3.1 Middle East & Africa IDH1 Antibody Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa IDH1 Antibody Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 IDH1 Antibody Market Drivers
12.2 IDH1 Antibody Market Restraints
12.3 IDH1 Antibody Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of IDH1 Antibody and Key Manufacturers
13.2 Manufacturing Costs Percentage of IDH1 Antibody
13.3 IDH1 Antibody Production Process
13.4 IDH1 Antibody Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 IDH1 Antibody Typical Distributors
14.3 IDH1 Antibody Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global IDH1 Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global IDH1 Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck IDH1 Antibody Product and Services
Table 6. Merck IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. GeneTex Basic Information, Manufacturing Base and Competitors
Table 9. GeneTex Major Business
Table 10. GeneTex IDH1 Antibody Product and Services
Table 11. GeneTex IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GeneTex Recent Developments/Updates
Table 13. Abcam Basic Information, Manufacturing Base and Competitors
Table 14. Abcam Major Business
Table 15. Abcam IDH1 Antibody Product and Services
Table 16. Abcam IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Abcam Recent Developments/Updates
Table 18. BosterBio Basic Information, Manufacturing Base and Competitors
Table 19. BosterBio Major Business
Table 20. BosterBio IDH1 Antibody Product and Services
Table 21. BosterBio IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. BosterBio Recent Developments/Updates
Table 23. Proteintech Group Basic Information, Manufacturing Base and Competitors
Table 24. Proteintech Group Major Business
Table 25. Proteintech Group IDH1 Antibody Product and Services
Table 26. Proteintech Group IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Proteintech Group Recent Developments/Updates
Table 28. Abnova Corporation Basic Information, Manufacturing Base and Competitors
Table 29. Abnova Corporation Major Business
Table 30. Abnova Corporation IDH1 Antibody Product and Services
Table 31. Abnova Corporation IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Abnova Corporation Recent Developments/Updates
Table 33. Novus Biologicals Basic Information, Manufacturing Base and Competitors
Table 34. Novus Biologicals Major Business
Table 35. Novus Biologicals IDH1 Antibody Product and Services
Table 36. Novus Biologicals IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Novus Biologicals Recent Developments/Updates
Table 38. NSJ Bioreagents Basic Information, Manufacturing Base and Competitors
Table 39. NSJ Bioreagents Major Business
Table 40. NSJ Bioreagents IDH1 Antibody Product and Services
Table 41. NSJ Bioreagents IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. NSJ Bioreagents Recent Developments/Updates
Table 43. LifeSpan BioSciences Basic Information, Manufacturing Base and Competitors
Table 44. LifeSpan BioSciences Major Business
Table 45. LifeSpan BioSciences IDH1 Antibody Product and Services
Table 46. LifeSpan BioSciences IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. LifeSpan BioSciences Recent Developments/Updates
Table 48. Abeomics Basic Information, Manufacturing Base and Competitors
Table 49. Abeomics Major Business
Table 50. Abeomics IDH1 Antibody Product and Services
Table 51. Abeomics IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Abeomics Recent Developments/Updates
Table 53. ProSci Basic Information, Manufacturing Base and Competitors
Table 54. ProSci Major Business
Table 55. ProSci IDH1 Antibody Product and Services
Table 56. ProSci IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. ProSci Recent Developments/Updates
Table 58. QED Bioscience Basic Information, Manufacturing Base and Competitors
Table 59. QED Bioscience Major Business
Table 60. QED Bioscience IDH1 Antibody Product and Services
Table 61. QED Bioscience IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. QED Bioscience Recent Developments/Updates
Table 63. Cell Signaling Technology Basic Information, Manufacturing Base and Competitors
Table 64. Cell Signaling Technology Major Business
Table 65. Cell Signaling Technology IDH1 Antibody Product and Services
Table 66. Cell Signaling Technology IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Cell Signaling Technology Recent Developments/Updates
Table 68. RayBiotech Basic Information, Manufacturing Base and Competitors
Table 69. RayBiotech Major Business
Table 70. RayBiotech IDH1 Antibody Product and Services
Table 71. RayBiotech IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. RayBiotech Recent Developments/Updates
Table 73. EpiGentek Basic Information, Manufacturing Base and Competitors
Table 74. EpiGentek Major Business
Table 75. EpiGentek IDH1 Antibody Product and Services
Table 76. EpiGentek IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. EpiGentek Recent Developments/Updates
Table 78. Enzo Life Sciences Basic Information, Manufacturing Base and Competitors
Table 79. Enzo Life Sciences Major Business
Table 80. Enzo Life Sciences IDH1 Antibody Product and Services
Table 81. Enzo Life Sciences IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Enzo Life Sciences Recent Developments/Updates
Table 83. OriGene Technologies Basic Information, Manufacturing Base and Competitors
Table 84. OriGene Technologies Major Business
Table 85. OriGene Technologies IDH1 Antibody Product and Services
Table 86. OriGene Technologies IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. OriGene Technologies Recent Developments/Updates
Table 88. Jingjie PTM BioLab Basic Information, Manufacturing Base and Competitors
Table 89. Jingjie PTM BioLab Major Business
Table 90. Jingjie PTM BioLab IDH1 Antibody Product and Services
Table 91. Jingjie PTM BioLab IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Jingjie PTM BioLab Recent Developments/Updates
Table 93. Beijing Solarbio Basic Information, Manufacturing Base and Competitors
Table 94. Beijing Solarbio Major Business
Table 95. Beijing Solarbio IDH1 Antibody Product and Services
Table 96. Beijing Solarbio IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Beijing Solarbio Recent Developments/Updates
Table 98. Biobyt Basic Information, Manufacturing Base and Competitors
Table 99. Biobyt Major Business
Table 100. Biobyt IDH1 Antibody Product and Services
Table 101. Biobyt IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Biobyt Recent Developments/Updates
Table 103. Global IDH1 Antibody Sales Quantity by Manufacturer (2018-2023) & (ml)
Table 104. Global IDH1 Antibody Revenue by Manufacturer (2018-2023) & (USD Million)
Table 105. Global IDH1 Antibody Average Price by Manufacturer (2018-2023) & (US$/ml)
Table 106. Market Position of Manufacturers in IDH1 Antibody, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 107. Head Office and IDH1 Antibody Production Site of Key Manufacturer
Table 108. IDH1 Antibody Market: Company Product Type Footprint
Table 109. IDH1 Antibody Market: Company Product Application Footprint
Table 110. IDH1 Antibody New Market Entrants and Barriers to Market Entry
Table 111. IDH1 Antibody Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global IDH1 Antibody Sales Quantity by Region (2018-2023) & (ml)
Table 113. Global IDH1 Antibody Sales Quantity by Region (2024-2029) & (ml)
Table 114. Global IDH1 Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 115. Global IDH1 Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 116. Global IDH1 Antibody Average Price by Region (2018-2023) & (US$/ml)
Table 117. Global IDH1 Antibody Average Price by Region (2024-2029) & (US$/ml)
Table 118. Global IDH1 Antibody Sales Quantity by Type (2018-2023) & (ml)
Table 119. Global IDH1 Antibody Sales Quantity by Type (2024-2029) & (ml)
Table 120. Global IDH1 Antibody Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Global IDH1 Antibody Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Global IDH1 Antibody Average Price by Type (2018-2023) & (US$/ml)
Table 123. Global IDH1 Antibody Average Price by Type (2024-2029) & (US$/ml)
Table 124. Global IDH1 Antibody Sales Quantity by Application (2018-2023) & (ml)
Table 125. Global IDH1 Antibody Sales Quantity by Application (2024-2029) & (ml)
Table 126. Global IDH1 Antibody Consumption Value by Application (2018-2023) & (USD Million)
Table 127. Global IDH1 Antibody Consumption Value by Application (2024-2029) & (USD Million)
Table 128. Global IDH1 Antibody Average Price by Application (2018-2023) & (US$/ml)
Table 129. Global IDH1 Antibody Average Price by Application (2024-2029) & (US$/ml)
Table 130. North America IDH1 Antibody Sales Quantity by Type (2018-2023) & (ml)
Table 131. North America IDH1 Antibody Sales Quantity by Type (2024-2029) & (ml)
Table 132. North America IDH1 Antibody Sales Quantity by Application (2018-2023) & (ml)
Table 133. North America IDH1 Antibody Sales Quantity by Application (2024-2029) & (ml)
Table 134. North America IDH1 Antibody Sales Quantity by Country (2018-2023) & (ml)
Table 135. North America IDH1 Antibody Sales Quantity by Country (2024-2029) & (ml)
Table 136. North America IDH1 Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 137. North America IDH1 Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Europe IDH1 Antibody Sales Quantity by Type (2018-2023) & (ml)
Table 139. Europe IDH1 Antibody Sales Quantity by Type (2024-2029) & (ml)
Table 140. Europe IDH1 Antibody Sales Quantity by Application (2018-2023) & (ml)
Table 141. Europe IDH1 Antibody Sales Quantity by Application (2024-2029) & (ml)
Table 142. Europe IDH1 Antibody Sales Quantity by Country (2018-2023) & (ml)
Table 143. Europe IDH1 Antibody Sales Quantity by Country (2024-2029) & (ml)
Table 144. Europe IDH1 Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 145. Europe IDH1 Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 146. Asia-Pacific IDH1 Antibody Sales Quantity by Type (2018-2023) & (ml)
Table 147. Asia-Pacific IDH1 Antibody Sales Quantity by Type (2024-2029) & (ml)
Table 148. Asia-Pacific IDH1 Antibody Sales Quantity by Application (2018-2023) & (ml)
Table 149. Asia-Pacific IDH1 Antibody Sales Quantity by Application (2024-2029) & (ml)
Table 150. Asia-Pacific IDH1 Antibody Sales Quantity by Region (2018-2023) & (ml)
Table 151. Asia-Pacific IDH1 Antibody Sales Quantity by Region (2024-2029) & (ml)
Table 152. Asia-Pacific IDH1 Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 153. Asia-Pacific IDH1 Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 154. South America IDH1 Antibody Sales Quantity by Type (2018-2023) & (ml)
Table 155. South America IDH1 Antibody Sales Quantity by Type (2024-2029) & (ml)
Table 156. South America IDH1 Antibody Sales Quantity by Application (2018-2023) & (ml)
Table 157. South America IDH1 Antibody Sales Quantity by Application (2024-2029) & (ml)
Table 158. South America IDH1 Antibody Sales Quantity by Country (2018-2023) & (ml)
Table 159. South America IDH1 Antibody Sales Quantity by Country (2024-2029) & (ml)
Table 160. South America IDH1 Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 161. South America IDH1 Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 162. Middle East & Africa IDH1 Antibody Sales Quantity by Type (2018-2023) & (ml)
Table 163. Middle East & Africa IDH1 Antibody Sales Quantity by Type (2024-2029) & (ml)
Table 164. Middle East & Africa IDH1 Antibody Sales Quantity by Application (2018-2023) & (ml)
Table 165. Middle East & Africa IDH1 Antibody Sales Quantity by Application (2024-2029) & (ml)
Table 166. Middle East & Africa IDH1 Antibody Sales Quantity by Region (2018-2023) & (ml)
Table 167. Middle East & Africa IDH1 Antibody Sales Quantity by Region (2024-2029) & (ml)
Table 168. Middle East & Africa IDH1 Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 169. Middle East & Africa IDH1 Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 170. IDH1 Antibody Raw Material
Table 171. Key Manufacturers of IDH1 Antibody Raw Materials
Table 172. IDH1 Antibody Typical Distributors
Table 173. IDH1 Antibody Typical Customers
List of Figures
Figure 1. IDH1 Antibody Picture
Figure 2. Global IDH1 Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global IDH1 Antibody Consumption Value Market Share by Type in 2022
Figure 4. Monoclonal Examples
Figure 5. Polyclonal Examples
Figure 6. Global IDH1 Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global IDH1 Antibody Consumption Value Market Share by Application in 2022
Figure 8. Immunochemistry (IHC) Examples
Figure 9. Immunofluorescence (IF) Examples
Figure 10. Immunoprecipitation (IP) Examples
Figure 11. Western Blot (WB) Examples
Figure 12. ELISA Examples
Figure 13. Others Examples
Figure 14. Global IDH1 Antibody Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global IDH1 Antibody Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global IDH1 Antibody Sales Quantity (2018-2029) & (ml)
Figure 17. Global IDH1 Antibody Average Price (2018-2029) & (US$/ml)
Figure 18. Global IDH1 Antibody Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global IDH1 Antibody Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of IDH1 Antibody by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 IDH1 Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 IDH1 Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global IDH1 Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global IDH1 Antibody Consumption Value Market Share by Region (2018-2029)
Figure 25. North America IDH1 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe IDH1 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific IDH1 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 28. South America IDH1 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa IDH1 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 30. Global IDH1 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global IDH1 Antibody Consumption Value Market Share by Type (2018-2029)
Figure 32. Global IDH1 Antibody Average Price by Type (2018-2029) & (US$/ml)
Figure 33. Global IDH1 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global IDH1 Antibody Consumption Value Market Share by Application (2018-2029)
Figure 35. Global IDH1 Antibody Average Price by Application (2018-2029) & (US$/ml)
Figure 36. North America IDH1 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America IDH1 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America IDH1 Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America IDH1 Antibody Consumption Value Market Share by Country (2018-2029)
Figure 40. United States IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe IDH1 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe IDH1 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe IDH1 Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe IDH1 Antibody Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific IDH1 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific IDH1 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific IDH1 Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific IDH1 Antibody Consumption Value Market Share by Region (2018-2029)
Figure 56. China IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America IDH1 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America IDH1 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America IDH1 Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America IDH1 Antibody Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa IDH1 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa IDH1 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa IDH1 Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa IDH1 Antibody Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. IDH1 Antibody Market Drivers
Figure 77. IDH1 Antibody Market Restraints
Figure 78. IDH1 Antibody Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of IDH1 Antibody in 2022
Figure 81. Manufacturing Process Analysis of IDH1 Antibody
Figure 82. IDH1 Antibody Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Table 1. Global IDH1 Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global IDH1 Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck IDH1 Antibody Product and Services
Table 6. Merck IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. GeneTex Basic Information, Manufacturing Base and Competitors
Table 9. GeneTex Major Business
Table 10. GeneTex IDH1 Antibody Product and Services
Table 11. GeneTex IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GeneTex Recent Developments/Updates
Table 13. Abcam Basic Information, Manufacturing Base and Competitors
Table 14. Abcam Major Business
Table 15. Abcam IDH1 Antibody Product and Services
Table 16. Abcam IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Abcam Recent Developments/Updates
Table 18. BosterBio Basic Information, Manufacturing Base and Competitors
Table 19. BosterBio Major Business
Table 20. BosterBio IDH1 Antibody Product and Services
Table 21. BosterBio IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. BosterBio Recent Developments/Updates
Table 23. Proteintech Group Basic Information, Manufacturing Base and Competitors
Table 24. Proteintech Group Major Business
Table 25. Proteintech Group IDH1 Antibody Product and Services
Table 26. Proteintech Group IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Proteintech Group Recent Developments/Updates
Table 28. Abnova Corporation Basic Information, Manufacturing Base and Competitors
Table 29. Abnova Corporation Major Business
Table 30. Abnova Corporation IDH1 Antibody Product and Services
Table 31. Abnova Corporation IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Abnova Corporation Recent Developments/Updates
Table 33. Novus Biologicals Basic Information, Manufacturing Base and Competitors
Table 34. Novus Biologicals Major Business
Table 35. Novus Biologicals IDH1 Antibody Product and Services
Table 36. Novus Biologicals IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Novus Biologicals Recent Developments/Updates
Table 38. NSJ Bioreagents Basic Information, Manufacturing Base and Competitors
Table 39. NSJ Bioreagents Major Business
Table 40. NSJ Bioreagents IDH1 Antibody Product and Services
Table 41. NSJ Bioreagents IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. NSJ Bioreagents Recent Developments/Updates
Table 43. LifeSpan BioSciences Basic Information, Manufacturing Base and Competitors
Table 44. LifeSpan BioSciences Major Business
Table 45. LifeSpan BioSciences IDH1 Antibody Product and Services
Table 46. LifeSpan BioSciences IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. LifeSpan BioSciences Recent Developments/Updates
Table 48. Abeomics Basic Information, Manufacturing Base and Competitors
Table 49. Abeomics Major Business
Table 50. Abeomics IDH1 Antibody Product and Services
Table 51. Abeomics IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Abeomics Recent Developments/Updates
Table 53. ProSci Basic Information, Manufacturing Base and Competitors
Table 54. ProSci Major Business
Table 55. ProSci IDH1 Antibody Product and Services
Table 56. ProSci IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. ProSci Recent Developments/Updates
Table 58. QED Bioscience Basic Information, Manufacturing Base and Competitors
Table 59. QED Bioscience Major Business
Table 60. QED Bioscience IDH1 Antibody Product and Services
Table 61. QED Bioscience IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. QED Bioscience Recent Developments/Updates
Table 63. Cell Signaling Technology Basic Information, Manufacturing Base and Competitors
Table 64. Cell Signaling Technology Major Business
Table 65. Cell Signaling Technology IDH1 Antibody Product and Services
Table 66. Cell Signaling Technology IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Cell Signaling Technology Recent Developments/Updates
Table 68. RayBiotech Basic Information, Manufacturing Base and Competitors
Table 69. RayBiotech Major Business
Table 70. RayBiotech IDH1 Antibody Product and Services
Table 71. RayBiotech IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. RayBiotech Recent Developments/Updates
Table 73. EpiGentek Basic Information, Manufacturing Base and Competitors
Table 74. EpiGentek Major Business
Table 75. EpiGentek IDH1 Antibody Product and Services
Table 76. EpiGentek IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. EpiGentek Recent Developments/Updates
Table 78. Enzo Life Sciences Basic Information, Manufacturing Base and Competitors
Table 79. Enzo Life Sciences Major Business
Table 80. Enzo Life Sciences IDH1 Antibody Product and Services
Table 81. Enzo Life Sciences IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Enzo Life Sciences Recent Developments/Updates
Table 83. OriGene Technologies Basic Information, Manufacturing Base and Competitors
Table 84. OriGene Technologies Major Business
Table 85. OriGene Technologies IDH1 Antibody Product and Services
Table 86. OriGene Technologies IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. OriGene Technologies Recent Developments/Updates
Table 88. Jingjie PTM BioLab Basic Information, Manufacturing Base and Competitors
Table 89. Jingjie PTM BioLab Major Business
Table 90. Jingjie PTM BioLab IDH1 Antibody Product and Services
Table 91. Jingjie PTM BioLab IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Jingjie PTM BioLab Recent Developments/Updates
Table 93. Beijing Solarbio Basic Information, Manufacturing Base and Competitors
Table 94. Beijing Solarbio Major Business
Table 95. Beijing Solarbio IDH1 Antibody Product and Services
Table 96. Beijing Solarbio IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Beijing Solarbio Recent Developments/Updates
Table 98. Biobyt Basic Information, Manufacturing Base and Competitors
Table 99. Biobyt Major Business
Table 100. Biobyt IDH1 Antibody Product and Services
Table 101. Biobyt IDH1 Antibody Sales Quantity (ml), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Biobyt Recent Developments/Updates
Table 103. Global IDH1 Antibody Sales Quantity by Manufacturer (2018-2023) & (ml)
Table 104. Global IDH1 Antibody Revenue by Manufacturer (2018-2023) & (USD Million)
Table 105. Global IDH1 Antibody Average Price by Manufacturer (2018-2023) & (US$/ml)
Table 106. Market Position of Manufacturers in IDH1 Antibody, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 107. Head Office and IDH1 Antibody Production Site of Key Manufacturer
Table 108. IDH1 Antibody Market: Company Product Type Footprint
Table 109. IDH1 Antibody Market: Company Product Application Footprint
Table 110. IDH1 Antibody New Market Entrants and Barriers to Market Entry
Table 111. IDH1 Antibody Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global IDH1 Antibody Sales Quantity by Region (2018-2023) & (ml)
Table 113. Global IDH1 Antibody Sales Quantity by Region (2024-2029) & (ml)
Table 114. Global IDH1 Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 115. Global IDH1 Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 116. Global IDH1 Antibody Average Price by Region (2018-2023) & (US$/ml)
Table 117. Global IDH1 Antibody Average Price by Region (2024-2029) & (US$/ml)
Table 118. Global IDH1 Antibody Sales Quantity by Type (2018-2023) & (ml)
Table 119. Global IDH1 Antibody Sales Quantity by Type (2024-2029) & (ml)
Table 120. Global IDH1 Antibody Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Global IDH1 Antibody Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Global IDH1 Antibody Average Price by Type (2018-2023) & (US$/ml)
Table 123. Global IDH1 Antibody Average Price by Type (2024-2029) & (US$/ml)
Table 124. Global IDH1 Antibody Sales Quantity by Application (2018-2023) & (ml)
Table 125. Global IDH1 Antibody Sales Quantity by Application (2024-2029) & (ml)
Table 126. Global IDH1 Antibody Consumption Value by Application (2018-2023) & (USD Million)
Table 127. Global IDH1 Antibody Consumption Value by Application (2024-2029) & (USD Million)
Table 128. Global IDH1 Antibody Average Price by Application (2018-2023) & (US$/ml)
Table 129. Global IDH1 Antibody Average Price by Application (2024-2029) & (US$/ml)
Table 130. North America IDH1 Antibody Sales Quantity by Type (2018-2023) & (ml)
Table 131. North America IDH1 Antibody Sales Quantity by Type (2024-2029) & (ml)
Table 132. North America IDH1 Antibody Sales Quantity by Application (2018-2023) & (ml)
Table 133. North America IDH1 Antibody Sales Quantity by Application (2024-2029) & (ml)
Table 134. North America IDH1 Antibody Sales Quantity by Country (2018-2023) & (ml)
Table 135. North America IDH1 Antibody Sales Quantity by Country (2024-2029) & (ml)
Table 136. North America IDH1 Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 137. North America IDH1 Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Europe IDH1 Antibody Sales Quantity by Type (2018-2023) & (ml)
Table 139. Europe IDH1 Antibody Sales Quantity by Type (2024-2029) & (ml)
Table 140. Europe IDH1 Antibody Sales Quantity by Application (2018-2023) & (ml)
Table 141. Europe IDH1 Antibody Sales Quantity by Application (2024-2029) & (ml)
Table 142. Europe IDH1 Antibody Sales Quantity by Country (2018-2023) & (ml)
Table 143. Europe IDH1 Antibody Sales Quantity by Country (2024-2029) & (ml)
Table 144. Europe IDH1 Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 145. Europe IDH1 Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 146. Asia-Pacific IDH1 Antibody Sales Quantity by Type (2018-2023) & (ml)
Table 147. Asia-Pacific IDH1 Antibody Sales Quantity by Type (2024-2029) & (ml)
Table 148. Asia-Pacific IDH1 Antibody Sales Quantity by Application (2018-2023) & (ml)
Table 149. Asia-Pacific IDH1 Antibody Sales Quantity by Application (2024-2029) & (ml)
Table 150. Asia-Pacific IDH1 Antibody Sales Quantity by Region (2018-2023) & (ml)
Table 151. Asia-Pacific IDH1 Antibody Sales Quantity by Region (2024-2029) & (ml)
Table 152. Asia-Pacific IDH1 Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 153. Asia-Pacific IDH1 Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 154. South America IDH1 Antibody Sales Quantity by Type (2018-2023) & (ml)
Table 155. South America IDH1 Antibody Sales Quantity by Type (2024-2029) & (ml)
Table 156. South America IDH1 Antibody Sales Quantity by Application (2018-2023) & (ml)
Table 157. South America IDH1 Antibody Sales Quantity by Application (2024-2029) & (ml)
Table 158. South America IDH1 Antibody Sales Quantity by Country (2018-2023) & (ml)
Table 159. South America IDH1 Antibody Sales Quantity by Country (2024-2029) & (ml)
Table 160. South America IDH1 Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 161. South America IDH1 Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 162. Middle East & Africa IDH1 Antibody Sales Quantity by Type (2018-2023) & (ml)
Table 163. Middle East & Africa IDH1 Antibody Sales Quantity by Type (2024-2029) & (ml)
Table 164. Middle East & Africa IDH1 Antibody Sales Quantity by Application (2018-2023) & (ml)
Table 165. Middle East & Africa IDH1 Antibody Sales Quantity by Application (2024-2029) & (ml)
Table 166. Middle East & Africa IDH1 Antibody Sales Quantity by Region (2018-2023) & (ml)
Table 167. Middle East & Africa IDH1 Antibody Sales Quantity by Region (2024-2029) & (ml)
Table 168. Middle East & Africa IDH1 Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 169. Middle East & Africa IDH1 Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 170. IDH1 Antibody Raw Material
Table 171. Key Manufacturers of IDH1 Antibody Raw Materials
Table 172. IDH1 Antibody Typical Distributors
Table 173. IDH1 Antibody Typical Customers
List of Figures
Figure 1. IDH1 Antibody Picture
Figure 2. Global IDH1 Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global IDH1 Antibody Consumption Value Market Share by Type in 2022
Figure 4. Monoclonal Examples
Figure 5. Polyclonal Examples
Figure 6. Global IDH1 Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global IDH1 Antibody Consumption Value Market Share by Application in 2022
Figure 8. Immunochemistry (IHC) Examples
Figure 9. Immunofluorescence (IF) Examples
Figure 10. Immunoprecipitation (IP) Examples
Figure 11. Western Blot (WB) Examples
Figure 12. ELISA Examples
Figure 13. Others Examples
Figure 14. Global IDH1 Antibody Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global IDH1 Antibody Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global IDH1 Antibody Sales Quantity (2018-2029) & (ml)
Figure 17. Global IDH1 Antibody Average Price (2018-2029) & (US$/ml)
Figure 18. Global IDH1 Antibody Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global IDH1 Antibody Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of IDH1 Antibody by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 IDH1 Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 IDH1 Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global IDH1 Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global IDH1 Antibody Consumption Value Market Share by Region (2018-2029)
Figure 25. North America IDH1 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe IDH1 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific IDH1 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 28. South America IDH1 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa IDH1 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 30. Global IDH1 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global IDH1 Antibody Consumption Value Market Share by Type (2018-2029)
Figure 32. Global IDH1 Antibody Average Price by Type (2018-2029) & (US$/ml)
Figure 33. Global IDH1 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global IDH1 Antibody Consumption Value Market Share by Application (2018-2029)
Figure 35. Global IDH1 Antibody Average Price by Application (2018-2029) & (US$/ml)
Figure 36. North America IDH1 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America IDH1 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America IDH1 Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America IDH1 Antibody Consumption Value Market Share by Country (2018-2029)
Figure 40. United States IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe IDH1 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe IDH1 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe IDH1 Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe IDH1 Antibody Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific IDH1 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific IDH1 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific IDH1 Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific IDH1 Antibody Consumption Value Market Share by Region (2018-2029)
Figure 56. China IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America IDH1 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America IDH1 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America IDH1 Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America IDH1 Antibody Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa IDH1 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa IDH1 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa IDH1 Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa IDH1 Antibody Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa IDH1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. IDH1 Antibody Market Drivers
Figure 77. IDH1 Antibody Market Restraints
Figure 78. IDH1 Antibody Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of IDH1 Antibody in 2022
Figure 81. Manufacturing Process Analysis of IDH1 Antibody
Figure 82. IDH1 Antibody Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
